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Macrophages and dendritic cells are heterogenous and
highly plastic bone marrow-derived cells that play major
roles in renal diseases. We characterized these cells using
immunohistochemistry in 55 renal biopsies from control
patients or patients with glomerulonephritis as an initial step
towards postulating specific roles for these cells in kidney
disease. In proliferative glomerulonephritis numerous CD68
positive (pan monocyte, macrophage and dendritic marker)
cells were found in both glomeruli and the tubulointerstitial
space, however, a myeloid dendritic cell marker (DC-SIGN)
was identified only in the tubulointerstitium. A significant
number of plasmacytoid dendritic cells (identified as BDCA-2
positive cells) were seen at sites of interstitial inflammation,
including follicular aggregates of inflammatory cells.
Langerin positive cells (a marker of Langerhans’ cells) were
detectable but rare. The area of either CD68 or DC-SIGN
positive interstitial cells correlated with serum creatinine.
Low levels of DC-SIGN, DC-LAMP and MHC class II mRNA
were present in the tubulointerstitial space in controls and
increased only in that region in proliferative
glomerulonephritis. We demonstrate that the CD68 positive
cells infiltrating the glomerulus lack dendritic cell markers
(reflecting macrophages), whereas in the tubulointerstitial
space the majority of CD68 positive cells are also DC-SIGN
positive (reflecting myeloid dendritic cells). Their number
correlated with serum creatinine, which further emphasizes
the significance of interstitial DCs in progressive glomerular
diseases.
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The mononuclear phagocyte system represents a family of
cells, including bone marrow progenitors, monocytes, tissue
macrophages, and specialized antigen-presenting cells, that is,
myeloid or conventional dendritic cells (mDCs).1,2
A substantial heterogeneity and plasticity exists both within
the Mac and DC lineage, which develop from bone marrow-
derived progenitor populations.1,3–6
DCs reside in tissues of most organs under normal
conditions and also function as ‘immunological sensors’ for
danger signals.7,8 Immature DCs capture antigen, change the
phenotype, and migrate to lymphoid organs, where the
mature DCs optimize clonal selection of rare T and B cells,
and initiate immune responses.9 A major difference between
Macs and DCs is that only DCs can activate naive T cells.10
For both Macs and DCs, various markers have been used
that differ substantially between humans and mice.11–15 Cells
with dendritic morphology and major histocompatibility
complex (MHC) class II expression were described in normal
rat and mouse kidney, and they were able to stimulate T-cell
responses in vitro.12,16,17 Fractalkine receptor-positive cells
formed a network within the normal mouse kidney, coex-
pressed CD11c, F4/80, and MHC class II, and demonstrated
immature costimulatory competence, but phagocytic ability.13
In the human kidney, data on DCs are scarce. CD68
(macrosialin) is commonly used as a pan monocyte–macro-
phage marker, but it was also present on DCs.18 CD68-
positive cells infiltrate the glomerular tuft and the tubuloin-
terstitium during glomerulonephritis (GN).19–21 A number of
surface markers have been used to characterize human DCs.
DC-SIGN (DC-specific intercellular adhesion molecule-3
(ICAM-3) grabbing, non-integrin; CD209) is a C-type lectin
that binds to ICAM-3 on T cells.22,23 Differentiation of
monocytes into immature DCs in vitro coincides with a
strong induction of DC-SIGN.22 DC-SIGN-positive cells
(most likely reflecting mDCs) have been found in tissue
sections from the lungs, intestine, cervix, placenta, lymph
nodes, and renal allografts.15 S100 has been described to be
expressed by Langerhans cells in the human skin and lymph
nodes,24 by DCs in human renal allografts,14 and by DCs in
rat lymph nodes.14,25–27 Langerin is a C-type lectin that is
expressed by Langerhans cells from the skin and small
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intestine.28,29 Langerin-positive cells are involved in immu-
nological surface surveillance. Blood dendritic cell antigen-2
(BDCA-2) is a type II C-type lectin that is expressed on
human CD11, CD123bright blood cells reflecting plasma-
cytoid DCs (pDCs).30,31 HLA-DR-positive DCs, which
coexpressed BDCA-1 (CD1c), a marker of mDCs and
BDCA-2-positive pDCs, were described in human renal
allografts and in IgA nephropathy.15
The aim of this study was to further characterize the
different populations of monocyte–macrophage–DCs and
their respective intrarenal location in biopsies from patients
with glomerular diseases as an initial step toward postulating
specific roles for these cells. Infiltrates in the glomerulus
lacked the classical markers for DCs, whereas cells with mDC
and pDC markers are commonly found in the renal
tubulointerstitium. CD68- and DC-SIGN-positive cells
correlated with renal function at the time of biopsy.
RESULTS
Distribution of cells with DC/Mac markers in normal renal
tissue
In normal renal tissue, CD68 stained round circulating cells
present in both glomerular and tubulointerstitial capillaries,
as well as in veins and arteries. Outside of the vascular lumen,
the tubulointerstitium contains a scattered population of
spindle-shaped CD68-positive cells between the tubuli and
the peritubular capillaries (Figure 1d).
In normal renal tissue from tumor nephrectomies or
biopsies without histopathological findings, DC-SIGN was
expressed by cells scattered throughout the tubulointersti-
tium (Figure 1a and b). The DC-SIGN-positive cells were
predominantly localized between tubules and peritubular
capillaries (Figure 1a). DC-SIGN-positive cells were not
detectable in glomeruli. Intrinsic renal cells, including cells of
the glomerular tuft, tubular epithelial cells, endothelial cells,
and cells of arterial vessel walls, were DC-SIGN negative. The
population of interstitial DC-SIGN-positive cells was smaller
than the population of CD68-positive cells on consecutive
sections. Because of the low numbers of these two cell types
in normal renal tissue, it was not possible to determine the
percentage of double-positive cells using consecutive sections.
As expected, S100 was expressed in renal nerves, parti-
cularly those accompanying larger vessels (Figure 1c).32 In addition,
a very small population of S100-positive cells with dendritic
morphology was found in the tubulointerstitium (Figure 1g).
Langerin was not found on intrinsic renal cells (Figure 1e
and f). A very small population of Langerin-positive cells was
localized around tubules. Additionally, some Langerin-positive
cells were detected between epithelial cells with morphological
characteristics of collecting tubular cells (columnar epithelium
without brush border; Figures 1f and 2i).
Distribution of cells with DC/Mac markers in GN
The basic morphological and clinical information available
on the study population is summarized in Table 1. In contrast
to the low number of DC-SIGN-positive cells in normal renal
tissue (Figure 1), a prominent accumulation of DC-SIGN-
positive cells was present in biopsies with lupus nephritis
(Figure 2b) or necrotizing GN (Figure 3b). The accumulation
of DC-SIGN-positive cells was restricted to the tubulointer-
stitial compartment (Figures 2b, e and 3b). DC-SIGN-
positive cells were associated with sites of interstitial injury
and at times clustered around injured glomeruli (Figure 2b).
There was considerable overlap between the pattern of CD68-
and DC-SIGN-positive cells in the tubulointerstitium,
indicating a large population of double-positive cells (Figures
2a, b and 3a, b, f, and g). To confirm this double-positive
population, we performed confocal double immunofluorescence
for DC-SIGN and CD68 on selected biopsies with lupus
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Figure 1 | DC/Mac markers in normal renal tissue.
Immunohistochemistry was performed on tissue sections from
histologically normal areas of tumor nephrectomies for (a, b)
DC-SIGN, (c, g) S100, (d) CD68, and (e, f) Langerin (original
magnification,  200 (b–d);  400 (a, e–g)). Note that there are
scattered positive cells in the tubulointerstitium with the highest
numbers for CD68 (arrows in panel d). S100 was expressed by
nerves (double arrow in panel c) and interstitial cells with
dendritic morphology (arrows in panels c and g). Examples of
positive cells are labeled with arrows.
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nephritis. By this method, the vast majority of DC-SIGN-
positive infiltrating cells in the tubulointerstitium were found
to be CD68 positive (Figure 2e–g). Owing to some tubular
background, a small DC-SIGN single-positive population
cannot be excluded. Additionally, there was a small popula-
tion of CD68-positive cells that were DC-SIGN negative.
In contrast to the prominent interstitial DC-SIGN-
positive cell population, DC-SIGN-positive cells were not
found within glomerular tufts (Figures 2b and 3b), even
though a prominent accumulation of CD68-positive cells was
present in the glomeruli (Figures 2a and 3a).
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Figure 2 | DC/Mac markers in lupus nephritis.
Immunohistochemistry was performed on sections from renal
biopsies with lupus nephritis for (a) CD68, (b) DC-SIGN, (c) S100, and
(d) Langerin. Original magnification  200. (a, b) There is a
prominent number of CD68-positive cells infiltrating the glomerular
tuft, which are DC-SIGN negative. In the tubulointerstitium, a
significant overlap between CD68 and DC-SIGN staining exists.
S100- and Langerin-positive cells were rare (arrow in panel d,
illustrated in higher magnification; original magnification  1000).
Double immunofluorescence was performed on a section from a
renal biopsy with lupus nephritis for (e) DC-SIGN and (f) CD68.
(g) Merged image of panels e and f (original magnification  630).
There is almost a complete overlap between the interstitial DC-SIGN
and CD68 (some of the double-positive cells are illustrated with
arrows). Double immunofluorescence was performed on a section
from a renal biopsy with membranous nephropathy for (h)
cytokeratin and (i) Langerin. Two Langerin-positive cells (arrows)
were clearly localized within the epithelial cell layer ((j) triple filter
with nuclei stained in blue with DAPI).
Table 1 | Clinical and morphological information on the study population
Disease n Gender (female) Age (years, range) Mean creatinine (mg per 100 ml) Proteinuria (g per 24 h)
Necrotizing GN 8 5 54 (38–77) 3.1 (1–4.7) 0.5 (0.3–0.6)
Lupus nephritis 8 8 35 (17–65) 2.9 (0.9–10) 3.9 (0.9–8)
MCD 8 1 56 (26–68) 1.6 (1–3) 7.2 (3.9–15)
FSGS 8 4 43 (15–80) 1.1 (0.6–1.7) 9.4 (0.8–15)
Membranous nephropathy 8 2 54 (16–79) 1.5 (0.7–2) 5.3 (2.5–8)
Minimal lesions 10 5 33 (17–55) 1.1 (0.8–1.9) 0.3 (0.1–0.6)
FSGS, focal-segmental glomerulosclerosis; GN, glomerulonephritis; MCD, minimal change disease.
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Figure 3 | DC/Mac markers in necrotizing GN and membranous
nephropathy. Immunohistochemistry was performed on sections
from renal biopsies (a–e) with necrotizing GN and (f–h) with
membranous nephropathy for (a, f) CD68, (b, g, h) DC-SIGN,
(c) S100, and (d, e) Langerin. Original magnification  200. (d and
e) Langerin-positive intraepithelial cells are illustrated (arrows).
Note the overlap between DC-SIGN- and CD68-positive cells
(arrows in panels f and g). (g) DC-SIGN signal was rarely found on
parietal epithelial cells. (g) A typical dendritic morphology is
shown by DC-SIGN-positive cells (arrow).
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CD68- and DC-SIGN-positive cells are difficult to
quantify because of their ‘dendritic’ morphology with
multiple long cell extensions and the clustering within the
tubulointerstitium. We therefore performed a morphometric
analysis quantifying the area of positive color product and
expressing it as a percentage of the measured area (either per
area of the high-power field or per glomerular tuft area). A
significant increase in the CD68-positive area was found in
renal biopsies with proliferative GN (Figure 4a and b),
with the most prominent accumulation in the glomeruli
(Figure 4b). In the tubulointerstitium, the relative percentage
of DC-SIGN-positive staining area was smaller than the area
positive for CD68 (Figure 4a and c), but a significant increase
of DC-SIGN-positive area was found (Figure 4c).
Scattered S100- and Langerin-positive cells were rarely
seen in the tubulointerstitium and were essentially absent
from glomerular tufts. Interestingly, Langerin-positive cells
were commonly found within epithelia with collecting-
tubular morphology (Figure 3d and e).
As examples of non-proliferative glomerular diseases, we
studied biopsies with focal–segmental glomerulosclerosis,
minimal change disease, and membranous GN (Figure 3).
In these diseases, the numbers of glomerular CD68-positive
cells were not significantly different compared to normal
controls. Again, the DC-SIGN-positive cells were restricted to
the tubulointerstitium. Occasionally, glomerular parietal
epithelial cells were found to be DC-SIGN positive,
predominantly in biopsies with non-proliferative GNs.
The area of positive staining for CD68 as well as for DC-
SIGN correlated significantly with the serum creatinine at the
time of biopsy (CD68: Spearman r¼ 0.41, P¼ 0.017;
DC-SIGN: Spearman r¼ 0.37, P¼ 0.035) but not with
proteinuria.
BDCA-2-positive cells in GN
In search of further markers to define subsets of DCs in
formalin-fixed, paraffin-embedded tissue, an antibody
against BDCA-2 (reflecting pDCs) was established.15,31,33
BDCA-2 has been used to identify pDCs in frozen tissue from
renal allografts.15 The cells were smaller than DC-SIGN-
positive cells, consistent with characteristics of pDCs in
human tonsils (Figure 5a).30,31,33
In normal renal tissue, only a minimal number of BDCA-2-
positive cells were seen within the tubulointerstitium. BDCA-2
was not present on renal parenchymal cells (Figure 5c–f).
Biopsies from patients with either proliferative or non-
proliferative GN demonstrated a higher number of BDCA-2-
positive cells in diseased interstitial areas (Figure 5).
In particular, areas of nodular inflammatory cell accumulations,
resembling tertiary lymphoid nodules, contained a prominent
number of BDCA-2-positive cells (Figure 5d). The accumulation
of BDCA-2-positive cells was restricted to the tubulointerstitium.
As DC-SIGN is considered a marker for mDCs and BDCA-2 for
pDCs, the interstitium contains both cell types.
Expression of CD68, DC-SIGN, DC-LAMP, Langerin, and
HLA-DRa mRNA in GN
To further characterize the expression of markers of Macs and
DCs, we used real-time reverse transcriptase-PCR on micro-
dissected renal biopsies with proliferative GN (including lupus
nephritis (n¼ 8) and crescentic GN (n¼ 8)). Six biopsies taken
from living donors before transplantation served as normal
controls (Figure 6). Expression of CD68 mRNA was found in
both the glomeruli and the tubulointerstitium (Figure 6a and
b). There was a trend toward higher expression in proliferative
GN, which, in contrast to the immunohistochemistry data, did
not reach the level of significance.
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Figure 4 | Morphometric quantification of DC/Mac markers. Morphometric analysis of the area of color product of (a, b) CD68 and (c, d)
DC-SIGN expressed as (a, c) a percentage of high-power field or (b, d) as per glomerular cross-section. Note that CD68 increases both in the
glomerulus and the tubulointerstitium, whereas DC-SIGN staining was almost exclusively restricted to the tubulointerstitium (c, d; *Po0,05,
**Po0,01, ***Po0,001).
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In the glomeruli, the levels of mRNA for DC-SIGN were
too low to be quantified. In contrast, expression was
detectable within the tubulointerstitial compartment, with a
significant increase in biopsies with proliferative GN (Figure
6c). Thus, the DC-SIGN mRNA expression data support the
results of the immunostaining. The expression of mRNA for
DC-LAMP as a marker of mature DCs was only significantly
increased in the tubulointerstitium of proliferative GN
(Figure 6d). Consistent with our immunohistological find-
ings, Langerin mRNA was not detectable in the glomeruli
from normal or diseased kidneys, but Langerin mRNA was
present in the tubulointerstitium of both normal and
diseased kidneys (Figure 6e). Finally, we quantified the
expression of MHC class II (reflected by HLA-DRa mRNA),
which was also upregulated only in the tubulointerstitial
compartment, but not in the glomeruli (Figure 6f and g). In
summary, a significant induction of mRNAs for markers
of DCs (DC-SIGN and DC-LAMP) and of MHC class II
(for antigen-presenting cells) was restricted to the
tubulointerstitium.
DISCUSSION
Macs and DCs play important roles in renal inflammation.
Both can show dynamic changes in their function and
phenotype.34,35 Generally, DCs are divided into mDCs and
pDCs. Human mDCs express BDCA-1 and DC-SIGN
(at least in most cases), whereas pDCs are positive for
BDCA-2.36 Furthermore, DCs can be manipulated to either
activate or suppress T-cell responses.10 In this regard, pDC
may play a role in generating regulatory T cells and
contributing to peripheral tolerance.37
Macs can be activated in a classical (interferon-g
dependent) and alternative manner (by T helper type 2
cytokines), resulting in proinflammatory versus anti-inflam-
matory phenotypes.10 These differences in phenotypes likely
reflect adaptation to different microenvironments.38
Therefore, both DCs and Macs could not only be involved
in the progression of the renal disease but may also
promote tolerance or healing processes.39 In human tissues,
including the kidney, different forms of Macs and DCs
remain poorly defined because of the lack of markers that
correlate with the functional phenotype. CD68 has been used
extensively as a marker for Macs. For example, in chronic
GN, the accumulation of CD68-positive cells in the
tubulointerstitium has been considered to represent
macrophage infiltration.35,40,41 Our results demonstrate that
CD68-positive cells infiltrating the glomeruli and the
tubulointerstitium represent different cell types as
determined by their surface markers. In the glomeruli, the
CD68-positive cells were negative for DC markers such as
DC-SIGN, Langerin, BDCA-2, and S100, indicating that they
were Macs.
By contrast, in the tubulointerstitium of biopsies with GN,
most CD68-positive cells were also DC-SIGN positive,
indicating that they were mDCs. The CD68/DC-SIGN double
positivity was confirmed by double fluorescence confocal
microscopy. In renal allografts and IgA nephropathy, it was
recently reported that DC-SIGN-positive cells also express
BDCA-1, another marker for mDCs.15 DC-SIGN facilitates
interaction with resting T cells (via ICAM-3) and allows for
the T-cell receptor to scan the DC surface to find the small
amounts of MHC–peptide ligands.22,23 DC-SIGN also binds
to Lewis X epitopes present on neutrophils and to a lesser
extent on monocytes.42,43 Thus, DC-SIGN combines the
function of a pattern recognition receptor and an adhesion
molecule, allowing interactions between immune cells
present in the injured tubulointerstitium.
In progressive kidney diseases, including proliferative GN,
T cells and CD68-positive cells accumulate in the tubuloin-
terstitium in parallel and with a similar distribution.19 Both
cell types correlate with renal function at the time of biopsy.44
In addition, we now demonstrate that the degree of
tubulointerstitial positivity for DC-SIGN correlates with
renal function at the time of biopsy in glomerular diseases.
Furthermore, the majority of CD68-positive cells, previously
considered to represent Macs, are also DC-SIGN positive.
Our findings in the tubulointerstitial involvement of primary
BDCA-2
BDCA-2 BDCA-2
BDCA-2 BDCA-2
IgG1
Figure 5 | pDCs in renal biopsies. Immunohistochemistry
performed with a monoclonal antibody against (a, c–f) BDCA-2 or
(b) isotype control immunoglobulin on (a, b) tissue sections from
the human tonsil or (c, d) renal biopsies from patients with lupus
nephritis, (e) necrotizing GN, and (f) membranous nephropathy
(original magnification,  200 (a–c, e, f);  400 (d)). (c, d) Note the
accumulation of BDCA-2-positive cells in areas of nodular
infiltrates (arrow). (e) BDCA-2-positive cells were restricted to
the tubulointerstitium, even in areas of severe glomerular injury.
(f) In membranous nephropathy, BDCA-2-positive cells were
present in areas of interstitial injury.
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glomerular diseases and those of Woltman et al.15 in renal
biopsies from transplants and IgA nephropathy underline the
significance of human renal DCs for the interstitial
component of kidney diseases.36 They also indicate that
CD68 positivity should no longer be equated with Macs in
the tubulointerstitium.
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Figure 6 | mRNA Expression of DC/Mac markers in renal biopsies. Quantification of mRNAs by real-time reverse transcriptase-PCR for
CD68 ((a) glomerular, (b) tubulointerstitium) and in the tubulointerstitium for (c) DC-SIGN, (d) DC-LAMP, and (e) Langerin. The expression
level of DC-SIGN, DC-LAMP, and Langerin in the glomeruli was too low to be quantified. MHC class II expression was significantly
upregulated (g) in the tubulointerstitium, but not (f) in the glomeruli.
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BDCA-2 is a marker for pDCs with the morphological
appearance of lymphocytes and the functionality of im-
mature DCs.30,31,33 Consistent with the data in biopsies from
renal transplants and IgA nephropathy, we found a
considerable number of BDCA-2-positive cells in the
tubulointerstitium of both proliferating and non-prolife-
rating forms of GN. The BDCA-2-positive pDCs were clearly
associated with sites of interstitial inflammation and were
frequently found in nodular mononuclear cell accumula-
tions, that is, tertiary lymphoid follicles.15 This may be of
particular interest, as pDCs are considered to play a role in
the peripheral generation of regulatory T cells and hence
peripheral tolerance.37
Our data on the differential infiltration of Macs and DCs
in the glomeruli and tubulointerstitium, respectively, may
indicate different pathophysiologies in these renal compart-
ments. Similar considerations appear to apply to DCs and
Macs in the murine kidney, as recent studies have demon-
strated that a significant percentage of F4/80-positive cells are
actually immature or resident DCs.12,13 Furthermore, in
mouse models of renal disease, the distribution of F4/80-
positive cells is predominantly restricted to the tubulointer-
stitium, whereas CD68-positive macrophages infiltrating the
glomeruli were essentially F4/80 negative.45 In human renal
allografts and in IgA nephropathy, a very low number of DC-
SIGN-positive cells were described in the glomeruli (1/50 and
1/12, respectively).15 In contrast, Morelli et al.46 described an
accumulation of DCs in the glomeruli and the tubulointer-
stitium in non-human primates after mobilization with Fms-
like tyrosine kinase 3 ligand. Our results are applicable to
only those antigens used here, particularly DC-SIGN, and
we cannot rule out a DC-SIGN-negative population of
intraglomerular DCs.
The rare appearance of DCs in the glomerulus is
noteworthy in the context that the glomerular compartment
is also rarely infiltrated by lymphocytes, either T or B cells, in
inflammatory renal diseases.47,48 In contrast, macrophages
and neutrophils are the predominant cell types recruited to
the glomerulus. A hypothetical, teleological explanation for
this finding might be that the glomerulus has to be
‘protected’ from antigen-processing DCs, as many circulating
molecules reach the mesangial area of the glomerulus because
of the high intraglomerular capillary pressure and its leaky,
fenestrated endothelium. DCs would be exposed to a
plethora of antigens, resulting in potentially massive local
immunological responses. The removal of locally accumula-
ting antigens is accomplished by mesangial cells serving as
housekeepers and, under marked immune complex deposi-
tion, by additional help from neutrophils and macrophages.
Thereby, an excessive acquired immune response would be
avoided, as it could endanger the delicate structure necessary
for glomerular function. The absence of DCs from the
glomerulus is also in keeping with the lack of lymphatics
draining the glomerulus. DCs leave the site of antigen
processing via lymphatic vessels to reach the draining lymph
nodes, and propagate an acquired immune response.49,50
Therefore, the absence of DCs from the glomerulus, the lack
of glomerular lymphatics, and the very rare glomerular T-cell
infiltrates may indicate that the glomerulus represents a
special immunological niche. The glomerulus might there-
fore react predominantly by an innate response, whereas the
tubulointerstitium with its resident DCs would, in addition,
be the site of an acquired immune response. This might be
one of the potential mechanisms whereby renal DCs could
contribute to progression of renal disease, a hypothesis that
should be further explored.
Our results show, for the first time, the presence of
Langerin-positive cells and Langerin mRNA in the tubuloin-
terstitial compartment of the human kidney. Langerin is a
glycoprotein expressed by Langerhans cells, which reside in
the epithelium of the skin and most mucosal surfaces.51 It is a
type II transmembrane C type lectin receptor, particularly for
mannose-containing structures, and has binding specificities
similar to DC-SIGN.52,53 Langerhans cells are a population of
immature DCs involved in antigen processing in the skin and
intestinal mucosa, but Langerin-positive DCs can be found in
diseased tissues, for example, in breast cancer.51,53,54 Langerin
mRNA was found to be expressed in the spleen, lymph nodes,
thymus, liver, lung, and heart in mice.55 By immunohisto-
chemistry, scattered Langerin-positive cells were present
adjacent to or even within tubules. Of particular interest
may be the close association of Langerin-positive cells with
tubular epithelia (commonly showing morphological
characteristics of collecting tubules). In this location,
Langerin-positive cells could perform a special immune
surveillance against ascending pathogens similar to the
function of Langerhans cells in the epidermis and intestinal
epithelium.
In summary, our data suggest that in the kidney, CD68-
positive cells comprise not only Macs, but also, and in the
tubulointerstitium to a major extent, DC-SIGN-positive
mDCs. Therefore, CD68 should no longer be used as a
marker for Macs, especially not in the renal tubulointer-
stitium. In biopsies from a variety of primary glomerular
diseases, we could show a significant correlation between
interstitial mDCs and serum creatinine at the time of biopsy,
potentially indicating that renal DCs may play a role in
interstitial disease progression. Furthermore, we described
BDCA-2-positive pDCs in the diseased tubulointerstitium
and, finally, a small population of Langerin-positive cells
surrounding or even incorporated in the tubular epithelial
layer. There they might perform a role in the local
surveillance against ascending pathogens, a hypothesis that
can now be tested.
MATERIALS AND METHODS
Study population
Biopsies with proliferative forms of GN included lupus nephritis
(n¼ 8) and necrotizing GN (n¼ 8). Non-proliferating glomerular
diseases were focal–segmental glomerulosclerosis (n¼ 8), membra-
nous nephropathy (n¼ 8), and minimal change disease (n¼ 8).
Biopsies without lesions and hence no identifiable disease (n¼ 10),
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and non-involved areas from tumor nephrectomies (n¼ 5), served
as controls. Ethical approval for the use of archival renal biopsy
material was given by the local committee for human subjects.
Immunohistochemistry
Immunohistochemistry was performed on 3 mm sections, as
previously described.44,56 As primary antibodies, the monoclonal
mouse anti-CD68 (Clone PG-M1; Dako, Germany, Hamburg),
mouse anti-DC-SIGN (CD209, clone DCN46; BD Pharmingen,
Heidelberg, Germany), mouse anti-Langerin (clone 12D6; Vector,
Burlingame, CA, USA), mouse anti-human BDCA-2 (Acris,
Hiddenhausen, Germany), and the polyclonal rabbit anti-
S100 (Dako) were used on consecutive sections. The antibodies
were tested in various dilutions, and with different antigen retrievals
on tissue from human tonsils (Figure 7).19,21 In addition to
perifollicular cells, CD68 stains a population of intrafollicular cells
(Figure 7a and b). DC-SIGN stains perifollicular cells with a stellate
shape (Figure 7d and e). Langerin stains intraepithelial cells as
expected and a smaller population of perifollicular cells (Figure 7g
and h). The smallest cell population is detected by S100
predominantly in the perifollicular area (Figure 7j). The
corresponding controls did not result in a black reaction product
(Figure 7c, f, i and k).
Immunofluorescence
Double-labeling immunofluorescence was performed on selected
biopsies for CD68/DC-SIGN and Langerin/cytokeratin, as
previously described.44
Real-time reverse transcriptase-PCR
The ERCB–KFB (the European Renal cDNA Bank–Kroener Fresenius
Biopsy Bank) is an international multicenter study of European
nephrology centers for the analysis of renal gene expression. Biopsy
specimens were manually microdissected in RNase inhibitor (for
details, see Cohen et al.57). Proper microdissection of glomerular
samples was confirmed after reverse transcription, by high
expression of Wilms tumor antigen 1 mRNA, as a marker for
glomerular epithelial cells. Informed consent was obtained before
renal biopsies were performed. Microdissected tubulointerstitial or
glomerular compartments were from biopsies with proliferative GNs
(lupus nephritis (n¼ 8) and crescentic GN (n¼ 8)) and compared
to pretransplantation kidney biopsies from living donors (pre-Tx;
n¼ 6). Real-time reverse transcriptase-PCR was performed on a
TaqMan ABI 7700 Sequence Detection System (Applied Biosystems,
Darmstadt, Germany) using heat-activated TaqDNA polymerase
(Amplitaq Gold; Applied Biosystems). Quantification of the given
templates was performed according to the standard curve method.
CD68 CD68
DC-SIGN
Langerin
S100 Serum
Langerin
DC-SIGN
Ig
Ig
Ig
Figure 7 | Establishment of the antibodies against DC/Mac markers on human tonsils. Immunohistochemistry was performed on
sections from human tonsils using monoclonal antibodies against (a, b) CD68, (d, e) DC-SIGN, (g, h) Langerin, and (j) a polyclonal antiserum
against S100, or (c, f, i, k) the corresponding isotype immunoglobulin controls (original magnification,  100 (d, f, g);  200 (a–c, h–k);
 400 (e)). Note the differences in antigen expression by cells in the follicles and the surrounding T-cell areas. Isotype controls did not result
in a positive color product.
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Commercially available predeveloped TaqMan reagents were used
for the target genes CD68, DC-SIGN, DC-LAMP, HLA-DRa,
Langerin (all from Applied Biosystems), and three endogenous
control genes (18S rRNA, cyclophilin A, GAPDH; Applied
Biosystems). The data shown in the text and figures are normalized
to 18S rRNA. All measurements were performed in duplicates.
Controls consisting of bidistilled H2O were negative in all runs. The
biopsy samples used for the mRNA analysis were from a different
cohort than the morphological study.
Confocal microscopy
Fluorescence images were captured with a Leica TCS SP2 Confocal
System, equipped with lasers exciting at 488 and 543 nm (Ar/Kr),
633 nm (HeNe), and 405 nm (diode laser) on a Leica DM IRBE
microscope stand with HCX PL APO 63 1.40 NA oil immersion
objective lens (Leica Microsystems, Heidelberg, Germany). To avoid
possible cross talk of the fluorochromes, the width of the detection
channels and filter settings were carefully controlled and images
were acquired using the sequential image recording method. For
evaluation of colocalization, single z-planes were analyzed with Leica
confocal software LCSLite (Leica Microsystems) and ImageJ 1.37
(Wright Cell Imaging Facility, Toronto, ON, Canada).
Digital image analysis
Morphometric analysis was performed on 15 consecutive high-power
fields (original magnification  400) or on 15 glomeruli by the use of
Qwin software (Leica, Bensheim, Germany).47 The area was measured
by an observer blinded to the diagnosis, and expressed as a fraction of
the area of the high-power field or area of the glomerular tuft.
Statistical analyses
For the comparison of means, the non-parametric Dunn’s multiple
comparison test and Spearman rank correlation were used for the
correlations between expression data (InStat Software, Version 3.05;
Intuitive Software for Science, San Diego, CA, USA). Po0.05 was
considered to be statistically significant.
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